₹1,810.45-31.90 (-1.73%)
04:01 PM, 19-Sep-2024₹1,810.05-31.45 (-1.71%)
03:54 PM, 19-Sep-2024BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 19-Sep-2024 | 04:01 PM IST
Market Cap (₹ Cr) | 29,836 |
Traded Value (₹ Cr) | 2.25 |
Volume (Shares) | 12,417 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,477.00 |
52-Week Low Date | 26-Oct-2023 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 29,830 |
EPS - TTM (₹) [C] | 43.83 |
P/E Ratio (X) [C] | 41.30 |
Face Value (₹) | 1 |
Latest Dividend (%) | 2,000.00 |
Latest Dividend Date | 16-Aug-2024 |
Dividend Yield (%) | 1.10 |
Book Value Share (₹) [C] | 529.51 |
P/B Ratio (₹) [C] | 3.42 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 1020.75 | 55,51,922 | 1.36 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 1020.75 | 55,51,922 | 1.36 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 1020.75 | 55,51,922 | 1.36 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 1020.75 | 55,51,922 | 1.36 |
Mirae Asset Large & Midcap Fund - Regular (G) | 677.93 | 36,87,292 | 1.69 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 677.93 | 36,87,292 | 1.69 |
Mirae Asset Large & Midcap Fund - Direct (IDCW) | 677.93 | 36,87,292 | 1.69 |
Mirae Asset Large & Midcap Fund - Direct (G) | 677.93 | 36,87,292 | 1.69 |
Nippon India Growth Fund - (G) | 514.79 | 28,00,000 | 1.53 |
Nippon India Growth Fund - (IDCW) | 514.79 | 28,00,000 | 1.53 |
Load more
Today's Low/High (₹) | 1,801.00 1,849.45 |
Week Low/High (₹) | 1,801.00 1,908.00 |
Month Low/High (₹) | 1,801.00 2,000.00 |
Year Low/High (₹) | 1,475.05 2,221.00 |
All time Low/High (₹) | 861.50 4,350.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -4.20% | -4.27% | 0.27 | 0.11% |
1 Month | -7.59% | -7.70% | 3.43 | 3.43% |
3 Month | -0.91% | -0.99% | 7.56 | 8.08% |
6 Month | 2.10% | 2.10% | 15.52 | 16.49% |
1 Year | 6.71% | 6.66% | 23.06 | 26.24% |
3 Year | -54.45% | -54.33% | 40.95 | 44.53% |
Chairman & Independent Directo : Yiu Kwan Stanley Lau
Executive Chairman & CEO : SRINIVAS SADU
Non-Exec & Non-Independent Dir : UDO JAHANNES VETTER
Independent Director : C S N Murthy
Independent Director : ESSAJI GOOLAM VAHANVATI
Independent Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Non Executive Director : Wenjie Zhang
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,810.45 at 04:01 PM IST on 19th Sep 2024. Gland Pharma Ltd share price was down by 1.73% from the previous closing price of Rs 1,842.35. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 29,836 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,477.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 222.92 crore on a total income of Rs 1,060.51 crore for the quarter ended 2024. For the year ended Jun 2024, Gland Pharma Ltd had posted a profit of Rs 143.76 crore on a total income of Rs 1,453.14 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Ipca Labs., Suven Pharma, Piramal Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Natco Pharma.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: